Unresectable or medically inoperable non-small cell lung cancer: The use of established clinical prognostic factors in making radiatior-related treatment decisions
- 31 October 2000
- journal article
- review article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 10 (4) , 267-273
- https://doi.org/10.1053/srao.2000.9130
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Radiotherapy Alone for Medically Inoperable Stage I Non-Small–Cell Lung Cancer: The Duke ExperienceInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy aloneInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Improved Survival in Stage III Non-Small-Cell Lung Cancer: Seven-Year Follow-up of Cancer and Leukemia Group B (CALGB) 8433 TrialJNCI Journal of the National Cancer Institute, 1996
- Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1995
- Prognostic factors in non-small cell lung cancerLung Cancer, 1994
- Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.Radiology, 1992
- Radiation therapy in the management of medically inoperable carcinoma of the lungs: Results and implications for future treatment strategiesInternational Journal of Radiation Oncology*Biology*Physics, 1992
- The Role of Surgery in N2 Lung CancerSurgical Clinics of North America, 1987
- A New International Staging System for Lung CancerChest, 1986
- Roentgenographic Evaluation of Mediastinal Nodes for Preoperative Assessment in Lung CancerChest, 1985